Australis Capital Inc. (AUSAF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 17, 2026, 4:00 PM EST
Australis Capital Company Description
Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.
Australis Capital Inc.
| Country | Canada |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Terrance Booth |
Contact Details
Address: 376 East Warm Springs Road Las Vegas, Nevada 89119 United States | |
| Phone | 800 898 0648 |
| Website | ausacap.com |
Stock Details
| Ticker Symbol | AUSAF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| ISIN Number | CA05259R1073 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Terrance R. Booth | Chief Executive Officer and Director |
| Dr. Jason Ronald Bradley Dyck Ph.D. | Chief Science Officer, Chairman of Scientific Advisory Board and Director |
| Robert Wilson | Chief Financial Officer |
| Roger Sykes | Chief Operating Officer |
| Paul E. Larsen | General Counsel |
| Marc Lakmaaker | Senior Vice President of Communications and Capital Markets |
| Fausto Aceituno Aceituno | Chief Marketing Officer |
| W. Campbell Birge B.A., BED, M.Sc. | Strategic Advisor |
| Randon Marcos | Director of Business Development |